Astrazeneca (AZN) Cash from Discontinued Operations (2009 - 2026)

Astrazeneca (AZN) has reported Cash from Discontinued Operations for 16 consecutive years, with 3359000000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Discontinued Operations fell 9.53% year-over-year to 3359000000.0; the TTM figure through Mar 2026 stood at 14221000000.0 (up 8.66% YoY), while the FY2025 annual figure was 14575000000.0, up 22.88% from the prior year.
• Cash from Discontinued Operations came in at 3359000000.0 for Q1 2026 at Astrazeneca, up from 2342000000.0 in the prior quarter.
• The five-year high for Cash from Discontinued Operations was 7965000000.0 in Q4 2023, with the low at 1248000000.0 in Q2 2022.
• Average Cash from Discontinued Operations over 5 years is 3633400000.0, with a median of 3232000000.0 recorded in 2022.
• Across the five-year window, Cash from Discontinued Operations soared 422.57% in 2022 and tumbled 63.5% in 2024, its largest moves.
• Year by year, Cash from Discontinued Operations stood at 7410000000.0 in 2022, then rose by 7.49% to 7965000000.0 in 2023, then sank by 63.5% to 2907000000.0 in 2024, then decreased by 19.44% to 2342000000.0 in 2025, then jumped by 43.42% to 3359000000.0 in 2026.
• According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 3359000000.0, 2342000000.0, and 5134000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.